Cross-Talks between RKIP and YY1 through a Multilevel Bioinformatics Pan-Cancer Analysis. [PDF]
Cancers (Basel), 2023 Baritaki S, Zaravinos A.
europepmc +1 more source
RKIP localizes to the nucleus through a bipartite nuclear localization signal and interaction with importin α to regulate mitotic progression. [PDF]
J Biol Chem, 2023 Argueta CE +5 more
europepmc +1 more source
Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure [PDF]
, 2013 core +1 more source
Marine Drug Discovery through Computer-Aided Approaches. [PDF]
Mar Drugs, 2023 GaudĂȘncio SP, Pereira F.
europepmc +1 more source
Changes in Expression of Tumor Suppressor Gene RKIP Impact How Cancers Interact with Their Complex Environment. [PDF]
Cancers (Basel), 2023 Figy C +5 more
europepmc +1 more source
RKIP: A Pivotal Gene Product in the Pathogenesis of Cancer. [PDF]
Cancers (Basel), 2022 Bonavida B.
europepmc +1 more source
Effects of Raf kinase inhibitor protein on biological characteristics of hepatocellular carcinoma cells and its potential therapeutic effects. [PDF]
ILIVER, 2022 Lin Z +4 more
europepmc +1 more source
Therapeutic effect of novel drug candidate, PRG-N-01, on NF2 syndrome-related tumor. [PDF]
Neuro OncolChung YH +16 more
europepmc +1 more source
Pan-Cancer Computational Analysis of RKIP (<i>PEBP1</i>) and LKB1 (<i>STK11</i>) Co-Expression Highlights Distinct Immunometabolic Dynamics and Therapeutic Responses Within the Tumor Microenvironment. [PDF]
Int J Mol SciSkouradaki E +5 more
europepmc +1 more source